Search
News Chat
Login
Search
Top
For You
Business
Crypto
Culture
Environment
Politics
Science
Sports
Tech
Video Games
World
Leqembi News
Top stories
Eisai and Biogen Launch Alzheimer's Drug Leqembi in China at USD24,800 per Year
Authors
5
5 days
China
Economics
Health
Articles
Latest stories
Eisai and Biogen Launch Alzheimer's Drug Leqembi in China at USD24,800 per Year
Authors
5
5 days
China
Economics
Health
Alzheon Closes $100M Financing, Biogen's Leqembi Positive Outlook
Authors
5
20 days
Bio
Science
FDA Releases Briefing Documents for Eli Lilly's Alzheimer's Drug Donanemab, Targeted Approval Considered
Authors
11
26 days
Bio
Science
Eisai and Biogen Submit BLA for Fast Track Injectable Alzheimer’s Drug Leqembi via Autoinjector
Authors
9
2 months
Bio
Science
Skepticism Among U.S. Doctors Slows Adoption of First Alzheimer's Slowing Drug, Leqembi
Authors
4
2 months
Economics
Crime
Business
Biogen's Stock Price Surges, Q1 Profits Exceed Estimates, Alzheimer's Drug Sales Soar
Authors
17
2 months
Bio
Crime
Science
Alzheimer's drug Leqembi by Eisai faces skepticism in US rollout, Biogen profits exceed estimates with sales nearly tripling to $19M
Authors
20
2 months
Economics
Crime
Business
Eisai and Biogen's Leqembi US Rollout Falls Short of Patient Target Amid Doctor Skepticism, Medicare Data Reveals Black-Box Warning
Authors
11
2 months
Bio
Crime
Science
Medicare Expects $3.5 Billion Spending on Alzheimer's Drug Leqembi in 2025 Raises Concerns
Authors
14
3 months
Bio
Crime
Science
Medicare's $3.5B Estimate for Leqembi Exceeds Expectations Amid Slow U.S. Market Start
Authors
11
3 months
Bio
Crime
Science
Biogen's Leqembi Sees Rising Demand with 2,000 Patients Taking Drug after FDA Approval; 3,800 Patients Signed Up
Authors
5
5 months
Bio
Science
Eisai to Launch Alzheimer's Drug Leqembi in China for 1,500 Patients, Expects Huge Growth in 2025
Authors
4
5 months
China
Economics
World
Injected Version of Alzheimer's Drug Leqembi Shows Promising Results in Study
Authors
16
8 months
Economics
Business
Experimental Under-the-Skin Injection of Eisai Co.'s Alzheimer's Drug Leqembi Shows Promising Results in Study
Authors
14
8 months
Economics
Business
Biogen's experimental tau-lowering Alzheimer's drug Leqembi shows promising results in study
Authors
13
8 months
Economics
Business
Biogen's Experimental Alzheimer's Drug, Leqembi, Shows Promise in Slowing Cognitive Decline in Study
Authors
13
8 months
Economics
Business
Previous
Next
